HOME >> BIOLOGY >> NEWS
Open source and open medicine take centre stage at UN research symposium

a new global paradigm that supports creativity, innovation and equitable access to knowledge.

In an open letter submitted to members of the World Health Organization Executive Board in January 2006, 280 eminent scientists from 50 countries noted: Although we have very varied scientific backgrounds, from basic research to specific clinical research, we are all deeply concerned with deficiencies in the way that biomedical research science is supported and translated into treatments that improve health outcomes around the world. In the research setting we see many possibilities to develop drugs to treat neglected diseases, but a lack of sustainable support for the R&D process. In the clinical setting we see the problem of affordable drugs to a greater or lesser extent in health care systems in all countries."

A recent UNU-MERIT Policy Brief on the role of Open Source and Open Standards in economic development similarly notes that: ".Countries around the world, regardless of their wealth, are trying to bring citizens into the Information Society and provide electronic access to government services. Many of them are considering open source software as a cost-effective means of doing so. Many more see an inherent injustice in requiring citizens and businesses to buy software from specific vendors in order to communicate with the government, and are looking at open standards - which allow different products from different producers, whether open source or proprietary software, to work together."

Research results from several Open Source studies at UNU-MERIT suggest that some countries and institutions have made strides in adopting policies to promote competition among technology providers, and enhance public access to knowledge. In just four years, Extremadura one of the poorest regions of Spain - successfully invested in creating a free-software society. The model is now being replicated in other poor regions of Spain, as well as in Latin A
'"/>

Contact: Louise Bergstrom
unuona@ony.unu.edu
212-963-6387
United Nations University
13-Apr-2006


Page: 1 2 3

Related biology news :

1. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
2. Bright future for nano-sized light source
3. Pointing a finger at the source of fecal bacteria
4. Alien plants attack using resource conservation as weapon, researchers say
5. Supermap of avian flu yields new info on source/spread
6. ESA open-source software supports Germanys TerraSAR-X
7. New agreement helps protect thousands of rice varieties -- the planets most important food source
8. Invitrogen features new scientific online resources at ASCB Meeting
9. Mixed prairie grasses are better biofuel source, U of M study says
10. Ocean sampling yields environmental sources of coral symbionts
11. Forum to explore thorium as abundant source of clean energy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Open source and open medicine take centre stage research symposium

(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
(Date:4/17/2015)... Houston, TX (PRWEB) April 17, 2015 ... genomics and proteomics technologies, announced today that it ... sequencing system, an innovative multiplex PCR based targeted ... ultra-high resolution sequence analysis, that enables accurate detection ... pending Relay-PCR™ and Omega-Primer™ technologies. The company will ...
(Date:4/16/2015)... 16, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) ... quarter results on Thursday, April 30, 2015 at 4:00 ... will host a conference call at 4:30 PM Eastern ... company’s outlook for the future. , The conference call ... the homepage and in the Investor Relations section of ...
(Date:4/16/2015)... According to the 2014 Liberty ... source was ranked first among the leading causes ... lifting, pushing, pulling, holding, carrying, or throwing and ... David Round Company takes statistics like this very ... to develop and design equipment that prevents these ...
(Date:4/16/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... venture with G-treeBNT (ReGenTree LLC) has retained Ora, ... for the orphan disorder, neurotrophic keratopathy (NK), and ... syndrome (DES) in the U.S.  Both trials will ... year.  Each of these eye disorders was being ...
Breaking Biology Technology:LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: